Suppr超能文献

通过对人甲状腺组分产生沉淀抗体以及鉴定一种与长效甲状腺刺激素(LATS)竞争甲状腺结合的抗体来比较甲状腺抗原。

Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.

作者信息

von Westarp C, Knox A J, Row V V, Volpé R

出版信息

Acta Endocrinol (Copenh). 1977 Apr;84(4):759-67. doi: 10.1530/acta.0.0840759.

Abstract

Antibodies were raised to various sub-cellular fractions of human thyroids, (of Graves' disease, Hashimoto's thyroiditis, and non-toxic goitre). With one exception it was found that antibodies to the Graves' thyroid fractions crooss-reacted with both the non-toxic goitre and Hashimoto's thyroiditis fractions. This exception was in the antiserum to the Graves' 105 000 x g pellet (Gr4) which contained an anr the Hashimoto's (/) thyroid preparations. The antibody-antigen between A-1 and Gr4 could be blocked by the addition of LATS (or TSH) to the antigen, thus suggesting that A- 1 might be a LATS-like immunoglobulin. These results suggest that the TSH receptor can be produced in vivo. Production of such an antibody to the TSH receptor would permit the development for the first time fo a good animal model of Graves' disease.

摘要

制备了针对人类甲状腺(格雷夫斯病、桥本甲状腺炎和非毒性甲状腺肿)各种亚细胞组分的抗体。除了一个例外情况,发现针对格雷夫斯病甲状腺组分的抗体与非毒性甲状腺肿和桥本甲状腺炎的组分都发生交叉反应。这个例外是针对格雷夫斯病105000×g沉淀(Gr4)的抗血清,它与桥本甲状腺炎(/)甲状腺制剂有反应。A - 1和Gr4之间的抗体 - 抗原反应可以通过向抗原中添加长效甲状腺刺激素(LATS)(或促甲状腺激素TSH)来阻断,因此表明A - 1可能是一种类LATS免疫球蛋白。这些结果表明促甲状腺激素(TSH)受体可以在体内产生。产生这样一种针对TSH受体的抗体将首次使得能够开发出一种良好的格雷夫斯病动物模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验